Literature DB >> 5808462

Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.

W A Pettinger, A Korn, H Spiegel, H M Solomon, R Pocelinko, W B Abrams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5808462     DOI： 10.1002/cpt1969105667

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  New drugs in hypertension.

Authors:  M G Myers
Journal:  Can Med Assoc J       Date:  1977-01-22       Impact factor: 8.262

2.  An analysis of the effects of amezinium on postganglionic sympathetic neurones.

Authors:  A Steppeler; R Pfändler; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

Review 3.  A new approach to biochemical evaluation of brain dopamine metabolism.

Authors:  I J Kopin; J H White; K Bankiewicz
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

4.  Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients.

Authors:  J H Silas; J Jones; G T Tucker; M M Townshend; C A Phillips; A J Smith
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.